[Immunosuppression in subacute sclerosing panencephalitis. A controlled study on the evolutive status of cerebrospinal fluid gamma globulin].
D000284:Administration, Oral; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008727:Methotrexate / Q000627:therapeutic use; D013344:Subacute Sclerosing Panencephalitis / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D005719:gamma-Globulins / Q000134:cerebrospinal fluid
D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D001379:Azathioprine; D008727:Methotrexate
Inmunosupresión en panencefalitis esclerosante subaguda. Un estudio controlado sobre los estadios evolutivos y los niveles de gamma-globulina del líquido cefalorraquídeo